Safety and Monitoring in CAR T Cell Therapy
Despite its remarkable efficacy, CAR T cell therapy requires careful patient monitoring due to possible side effects. Cytokine release syndrome (CRS) is a common complication, caused by rapid immune activation, and can lead to fever, hypotension, and organ dysfunction. Neurotoxicity is another potential risk, manifesting as confusion, seizures, or difficulty speaking.
Specialized care units and standardized protocols help manage these effects effectively. Early intervention using immunosuppressive therapies and supportive care measures has improved safety outcomes and patient recovery.
As technology advances, researchers are developing next-generation CAR T cells with built-in safety switches, allowing doctors to deactivate the cells if severe side effects occur. These innovations ensure therapy remains both effective and safe for patients.